Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2002
03/21/2002WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022602A2 Triazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022600A2 Chemokine receptor binding heterocyclic compounds
03/21/2002WO2002022599A2 Chemokine receptor binding heterocyclic compounds
03/21/2002WO2002022598A1 Quinolinone derivatives as tyrosine kinase inhibitors
03/21/2002WO2002022597A1 N-phenyl-2-pyrimidine-amine derivatives
03/21/2002WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists
03/21/2002WO2002022588A1 Novel pyrimidine derivative and novel pyridine derivative
03/21/2002WO2002022587A1 Pyridazinones and triazinones and medicinal use thereof
03/21/2002WO2002022585A1 Tetrahydroquinoline compounds
03/21/2002WO2002022579A2 Antipsychotic sulfonamide-heterocycles, and methods of use thereof
03/21/2002WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors
03/21/2002WO2002022576A2 3-substituted indole carbohydrazides useful as cell proliferation and angiogenesis inhibitors
03/21/2002WO2002022575A1 Amidine inhibitors of serine proteases
03/21/2002WO2002022572A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
03/21/2002WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs
03/21/2002WO2002022126A1 Gatifloxacin pentahydrate
03/21/2002WO2002022123A1 Alpha v integrin receptor antagonists
03/21/2002WO2002006255A3 Hydroxy-(piperidin-4-yl-methylamino)-alkyl beta-3 adrenergic receptor antagonists
03/21/2002WO2001095858A3 Piperazinedione compounds
03/21/2002WO2001087846A3 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/21/2002WO2001074813A3 METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS
03/21/2002WO2001066099A3 Use of quinazoline derivatives as angiogenesis inhibitors
03/21/2002WO2001064826A3 Composition and method for bleaching a substrate
03/21/2002WO2001064197A3 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
03/21/2002WO2001055106A3 Novel melanocortin receptor agonists and antagonists
03/21/2002US20020035267 Tetrazolyl-phenyl acetamide glucokinase activators
03/21/2002US20020035266 Tetrazolyl-phenyl acetamide glucokinase activators
03/21/2002US20020035263 Novel arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives
03/21/2002US20020035255 Process for preparing pyridinemethanol compounds
03/21/2002US20020035140 1-(pyrrlolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
03/21/2002US20020035134 Indoline derivatives useful as 5-HT-2C receptor antagonists
03/21/2002US20020035127 Phenylalanine derivatives
03/21/2002US20020035121 Aryl fused substituted 4-oxy-pyridines
03/21/2002US20020035115 Thrombin inhibitors
03/21/2002US20020035109 Benzamidine derivatives and their use as anti-coagulants
03/21/2002US20020035103 For diseases or conditions caused by or exacerbated by histamine-3 receptor activity
03/21/2002US20020035102 Azetidine derivatives, their preparation and medicaments containing them
03/21/2002US20020035094 Substituted pyridine compounds and methods of use
03/21/2002US20020035092 Propanoic acid derivatives
03/21/2002US20020032937 Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing
03/21/2002DE10045530A1 Kombinatorische Herstellung einer Substanzbibliothek unter Abtrennung einer zwitterionischen Verbindung durch Fällung Combinatorial preparation of a compound library with removal of a zwitterionic compound by precipitation
03/21/2002DE10044905A1 (2-Azabicyclo[2.2.1]hept-7-yl)methanol-Derivate als nikontinische Acetylcholinrezeptor Agonisten (2-azabicyclo [2.2.1] hept-7-yl) methanol derivatives as nikontinische acetylcholine receptor agonists
03/21/2002CA2742411A1 Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations
03/21/2002CA2687476A1 N-phenyl-2-pyrimidine-amine derivatives
03/21/2002CA2422616A1 Gatifloxacin pentahydrate
03/21/2002CA2422137A1 Tetrahydroquinoline compounds
03/21/2002CA2422055A1 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
03/21/2002CA2422013A1 Substituted urea neuropeptide y y5 receptor antagonists
03/21/2002CA2421792A1 Alpha v integrin receptor antagonists
03/21/2002CA2421054A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
03/21/2002CA2419224A1 Chemokine receptor binding heterocyclic compounds
03/21/2002CA2419219A1 Chemokine receptor binding heterocyclic compounds
03/21/2002CA2418720A1 Caspase inhibitors and uses thereof
03/20/2002EP1188755A1 Acylhydrazine derivatives, process for preparing the same and use thereof
03/20/2002EP1188754A1 Substituted pyrazole compounds
03/20/2002EP1188747A1 Phenoxypropylamine compounds
03/20/2002EP1188732A2 Combinatorial synthesis of a chemical library involving the separation of a zwitterionic compound by precipitation
03/20/2002EP1187856A1 Transition metal complexes and olefin polymerization process
03/20/2002EP1187835A1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
03/20/2002EP1187833A1 Method of producing nitroguanidine- and nitroenamine derivatives
03/20/2002EP1187828A1 Quinoline derivatives as antibacterials
03/20/2002EP1187827A1 Antiviral agents
03/20/2002EP1187818A1 Pesticidally active tetrazine derivatives
03/20/2002EP1187816A1 5-cyano-2-aminopyrimidine derivatives
03/20/2002EP1187815A1 4-phenyl-pyrimidine derivatives
03/20/2002EP1187814A2 5-phenyl-pyrimidine derivatives
03/20/2002EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis
03/20/2002EP1187812A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
03/20/2002EP1187811A1 Inhibitors of metalloproteinases
03/20/2002EP1187810A2 Heterocyclic analgesic compounds and their use
03/20/2002EP1187614A1 Substituted piperidines as melanocortin-4 receptor agonists
03/20/2002EP1187592A2 Alpha v integrin receptor antagonists
03/20/2002EP1019050B1 Use of somatostatin agonists and antagonists for treating diseases related to the eye
03/20/2002CN1341115A 16-halogen-epothilone derivatives, process for producing them and their pharmaceutical use
03/20/2002CN1341104A 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
03/20/2002CN1341103A Pyridazin-3-one derivatives and medicines containing the same
03/20/2002CN1341101A Phenyl-and pyridinyl derivatives
03/20/2002CN1341100A 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
03/20/2002CN1341099A 2-aminopyridines containing fused ring substituents
03/20/2002CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
03/19/2002US6359151 Use as pesticides.
03/19/2002US6359138 4-hydroxy-piperidine derivatives
03/19/2002US6359137 Antibiotic
03/19/2002US6359134 Sulfonamide derivatives, their production and use
03/19/2002US6358994 2-acylaminopropanamines as tachykinin receptor antagonists
03/19/2002US6358993 Pharmaceutically active nitrogen ring compounds and methods of use thereof
03/19/2002US6358979 N-cyclopentyl modulators of chemokine receptor activity
03/19/2002US6358978 Substituted benzimidazoles
03/19/2002US6358976 For therapy and prophylaxis of cancer metastasis, diabetic retinopathy, neovascular glaucoma, thrombosis, restenosis, osteoporosis, or macular degeneration
03/19/2002US6358974 Used as as modulators of dopamine d.sub.3 receptors, in therapy as antipsychotic agents
03/19/2002US6358973 For therapy of allergic or inflammatory disease
03/19/2002US6358972 5-HT1F agonists
03/19/2002US6358970 Integrin receptor antagonists
03/19/2002US6358968 N-substituted urea inhibitors of farnesyl-protein transferase
03/19/2002US6358962 6,7-Dimethoxyquinazolines and therapeutic use thereof
03/19/2002US6358961 Farnesyltransferase inhibiting quinazolinones
03/19/2002US6358960 For therapy of intravascular coagulation, coronary thrombosis, cerebral infarction, cerebral embolism, transient ischemic attack, cerebrovascular disorders, pulmonary vascular diseases, deep venous thrombosis, etc.
1 ... 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 ... 1080